Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The effect of high-flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation

J. Malik, A. Valerianova, V. Tuka, P. Trachta, V. Bednarova, Z. Hruskova, M. Slavikova, MH. Rosner, V. Tesar

. 2021 ; 8 (3) : 2165-2171. [pub] 20210323

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

AIMS: High-flow arteriovenous fistula (AVF) for haemodialysis leads to profound haemodynamic changes and sometimes to heart failure (HF). Cardiac output (CO) is divided between the AVF and body tissues. The term effective CO (COef) represents the difference between CO and AVF flow volume (Qa) and better characterizes the altered haemodynamics that may result in organ hypoxia. We investigated the effects of Qa reduction on systemic haemodynamics and on brain oxygenation. METHODS AND RESULTS: This is a single-centre interventional study. Twenty-six patients on chronic haemodialysis with high Qa (>1500 mL/min) were indicated for surgical Qa reduction for HF symptoms and/or signs of structural heart disease on echocardiography. The included patients underwent three sets of examinations: at 4 months and then 2 days prior and 6 weeks post-surgical procedure. Clinical status, echocardiographical haemodynamic assessment, Qa, and brain oximetry were recorded. All parameters remained stable from selection to inclusion. After the procedure, Qa decreased from 3.0 ± 1.4 to 1.3 ± 0.5 L/min, P < 0.00001, CO from 7.8 ± 1.9 to 6.6 ± 1.5 L/min, P = 0.0002, but COef increased from 4.6 ± 1.4 to 5.3 ± 1.4 L/min, P = 0.036. Brain tissue oxygen saturation increased from 56 ± 11% to 60 ± 9%, P = 0.001. CONCLUSIONS: Qa reduction led to increased COef. This was explained by a decreased proportion of CO running through the AVF in patients with Qa > 2.0 L/min. These observations were mirrored by higher brain oxygenation and might explain HF symptoms and improved haemodynamics even in asymptomatic high Qa patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025654
003      
CZ-PrNML
005      
20211026133623.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ehf2.13305 $2 doi
035    __
$a (PubMed)33755355
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Malik, Jan $u Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U Nemocnice 1, Prague, 128 08, Czech Republic
245    14
$a The effect of high-flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation / $c J. Malik, A. Valerianova, V. Tuka, P. Trachta, V. Bednarova, Z. Hruskova, M. Slavikova, MH. Rosner, V. Tesar
520    9_
$a AIMS: High-flow arteriovenous fistula (AVF) for haemodialysis leads to profound haemodynamic changes and sometimes to heart failure (HF). Cardiac output (CO) is divided between the AVF and body tissues. The term effective CO (COef) represents the difference between CO and AVF flow volume (Qa) and better characterizes the altered haemodynamics that may result in organ hypoxia. We investigated the effects of Qa reduction on systemic haemodynamics and on brain oxygenation. METHODS AND RESULTS: This is a single-centre interventional study. Twenty-six patients on chronic haemodialysis with high Qa (>1500 mL/min) were indicated for surgical Qa reduction for HF symptoms and/or signs of structural heart disease on echocardiography. The included patients underwent three sets of examinations: at 4 months and then 2 days prior and 6 weeks post-surgical procedure. Clinical status, echocardiographical haemodynamic assessment, Qa, and brain oximetry were recorded. All parameters remained stable from selection to inclusion. After the procedure, Qa decreased from 3.0 ± 1.4 to 1.3 ± 0.5 L/min, P < 0.00001, CO from 7.8 ± 1.9 to 6.6 ± 1.5 L/min, P = 0.0002, but COef increased from 4.6 ± 1.4 to 5.3 ± 1.4 L/min, P = 0.036. Brain tissue oxygen saturation increased from 56 ± 11% to 60 ± 9%, P = 0.001. CONCLUSIONS: Qa reduction led to increased COef. This was explained by a decreased proportion of CO running through the AVF in patients with Qa > 2.0 L/min. These observations were mirrored by higher brain oxygenation and might explain HF symptoms and improved haemodynamics even in asymptomatic high Qa patients.
650    12
$a arteriovenózní píštěl $7 D001164
650    12
$a arteriovenózní zkrat $7 D001166
650    _2
$a mozek $x diagnostické zobrazování $7 D001921
650    _2
$a hemodynamika $7 D006439
650    _2
$a lidé $7 D006801
650    _2
$a dialýza ledvin $7 D006435
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Valerianova, Anna $u Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U Nemocnice 1, Prague, 128 08, Czech Republic
700    1_
$a Tuka, Vladimir $u Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U Nemocnice 1, Prague, 128 08, Czech Republic
700    1_
$a Trachta, Pavel $u Third Department of Internal Medicine, General University Hospital, First Faculty of Medicine, Charles University, U Nemocnice 1, Prague, 128 08, Czech Republic
700    1_
$a Bednarova, Vladimira $u Department of Nephrology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hruskova, Zdenka $u Department of Nephrology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Slavikova, Marcela $u Second Department of Surgery, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Rosner, Mitchell H $u Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA
700    1_
$a Tesar, Vladimir $u Department of Nephrology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00197251 $t ESC heart failure $x 2055-5822 $g Roč. 8, č. 3 (2021), s. 2165-2171
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33755355 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133629 $b ABA008
999    __
$a ok $b bmc $g 1714622 $s 1146161
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 8 $c 3 $d 2165-2171 $e 20210323 $i 2055-5822 $m ESC heart failure $n ESC Heart Fail $x MED00197251
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...